{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:09:12Z","timestamp":1770743352050,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10822-013-9667-1","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T17:10:25Z","timestamp":1374685825000},"page":"637-654","source":"Crossref","is-referenced-by-count":18,"title":["Pyridones as NNRTIs against HIV-1 mutants: 3D-QSAR and protein informatics"],"prefix":"10.1007","volume":"27","author":[{"given":"Utsab","family":"Debnath","sequence":"first","affiliation":[]},{"given":"Saroj","family":"Verma","sequence":"additional","affiliation":[]},{"given":"Surabhi","family":"Jain","sequence":"additional","affiliation":[]},{"given":"Setu B.","family":"Katti","sequence":"additional","affiliation":[]},{"given":"Yenamandra S.","family":"Prabhakar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"9667_CR1","unstructured":"Global report: UNAIDS report on the global AIDS epidemic (2012) http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_en.pdf . Accessed on 9 April 2013"},{"key":"9667_CR2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ni0603-501","volume":"4","author":"N Imami","year":"2003","unstructured":"Imami N, Gotch F (2003) Twenty years of HIV-1 research: what the future holds. Nat Immunol 4:501","journal-title":"Nat Immunol"},{"key":"9667_CR3","unstructured":"http:\/\/www.ncbi.nlm.nih.gov\/genome\/?term=txid11676[Organism:exp]"},{"key":"9667_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/med.2610130303","volume":"13","author":"ED Clercq","year":"1993","unstructured":"Clercq ED (1993) HIV-1specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase. Med Res Rev 13:229\u2013258","journal-title":"Med Res Rev"},{"key":"9667_CR5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1126\/science.7532321","volume":"267","author":"RA Spence","year":"1995","unstructured":"Spence RA, Kati WM, Anderson KS, Johnson KA (1995) Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science 267:988\u2013993","journal-title":"Science"},{"key":"9667_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nsb0495-303","volume":"2","author":"R Esnouf","year":"2006","unstructured":"Esnouf R, Ren J, Ross C, Jones Y, Stammers D, Stuart D (2006) Mechanism of inhibition of HIV-1 reverse transcriptase by non- nucleoside inhibitors. Nat Struct Biol 2:303\u2013308","journal-title":"Nat Struct Biol"},{"key":"9667_CR7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1371\/journal.ppat.0020119","volume":"2","author":"A Figueiredo","year":"2006","unstructured":"Figueiredo A, Moore Katie L, Mak J, Sluis-Cremer N, de Bethune MP, Tachedjian G (2006) Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol. PLoS Pathog 2:1051\u20131059","journal-title":"PLoS Pathog"},{"key":"9667_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","volume":"85","author":"MP B\u00e9thune De","year":"2010","unstructured":"De B\u00e9thune MP (2010) Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20\u00a0years (1989\u20132009). Antivir Res 85:75\u201390","journal-title":"Antivir Res"},{"key":"9667_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virusres.2007.12.018","volume":"134","author":"J Ren","year":"2008","unstructured":"Ren J, Stammers DK (2008) Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. Virus Res 134:157\u2013170","journal-title":"Virus Res"},{"key":"9667_CR10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.44.4.920-928.2000","volume":"44","author":"CJ Petropoulos","year":"2000","unstructured":"Petropoulos CJ, Parkin NT, Limoli KL, Lie YS, Wrin T, Huang W, Tian H, Smith D, Winslow GA, Capon DJ, Whitcomb JM (2000) A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother 44:920\u2013928","journal-title":"Antimicrob Agents Chemother"},{"key":"9667_CR11","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/AAC.39.12.2602","volume":"39","author":"SD Young","year":"1995","unstructured":"Young SD, Britcher SF, Tran LO, Payne LS, Lumma WC, Lyle TA, Huff JR, Anderson PS, Olsen DB, Carroll SS (1995) L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 39:2602\u20132605","journal-title":"Antimicrob Agents Chemother"},{"key":"9667_CR12","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/AAC.37.8.1576","volume":"37","author":"VW Byrnes","year":"1993","unstructured":"Byrnes VW, Sardana VV, Schleif WA, Condra JH, Waterbury JA, Wolfgang JA, Long WJ, Schneider CL, Schlabach AJ, Wolanski BS, Graham DJ, Gotlib L, Rhodes A, Titus DL, Roth E, Blahy OM, Quintero JC, Satszewski S, Emini EA (1993) Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. Antimicrob Agents Chemother 37:1576\u20131579","journal-title":"Antimicrob Agents Chemother"},{"key":"9667_CR13","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/jm0408621","volume":"48","author":"A Benjahad","year":"2005","unstructured":"Benjahad A, Croisy M, Monneret C, Bisagni E, Mabire D, Coupa S, Poncelet A, Csoka I, Guillemont J, Meyer C, Andries K, Pauwels R, de Bthune MP, Himmel DM, Das K, Arnold E, Nguyen CH, Grierson David S (2005) 4-Benzyl and 4-Benzoyl-3- dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5, 6-alkyl-substituted analogues against clinically important hiv mutant strains. J Med Chem 48:1948\u20131964","journal-title":"J Med Chem"},{"key":"9667_CR14","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1021\/jm900802y","volume":"52","author":"J Guillemont","year":"2009","unstructured":"Guillemont J, Benjahad A, Oumouch S, Decrane L, Palandjian P, Vernier D, Queguiner L, Andries K, de Bethune MP, Hertogs K, Grierson David S, Nguyen CH (2009) Synthesis and biological evaluation of C-5 methyl substituted 4-arylthio and 4-aryloxy-3-iodopyridin-2(1H)-one type anti-HIV agents. J Med Chem 52:7473\u20137487","journal-title":"J Med Chem"},{"key":"9667_CR15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bmcl.2006.10.082","volume":"17","author":"A Benjahad","year":"2006","unstructured":"Benjahad A, Oumouch S, Guillemont J, Pasquir E, Mabire D, Andries K, Nguyen CH, Grierson DS (2006) Structure-activity relationship in the 3-iodo-4-phenoxypyridinone(IOPY) series: the nature of the C-3 substituent on anti-HIV activity. Bioorg Med Chem 17:712\u2013716","journal-title":"Bioorg Med Chem"},{"key":"9667_CR16","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/cr9703358","volume":"99","author":"R Garg","year":"1999","unstructured":"Garg R, Gupta SP, Gao H, Babu MS, Debnath AK, Hansch C (1999) Comparative quantitative structure-activity relationship studies on anti-HIV drugs. Chem Rev 99:3525\u20133601","journal-title":"Chem Rev"},{"key":"9667_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/10629360600884520","volume":"17","author":"P Pungpo","year":"2006","unstructured":"Pungpo P, Saparpakorn P, Wolschann P, Hannongbua S (2006) Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives. SAR QSAR Environ Res 17:353\u2013370","journal-title":"SAR QSAR Environ Res"},{"key":"9667_CR18","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/jm7012198","volume":"51","author":"J Carlsson","year":"2008","unstructured":"Carlsson J, Boukharta L, Aqvist J (2008) Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase. J Med Chem 51:2648\u20132656","journal-title":"J Med Chem"},{"key":"9667_CR19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/qsar.200330854","volume":"23","author":"YS Prabhakar","year":"2004","unstructured":"Prabhakar YS, Solomon VR, Rawal RK, Gupta MK, Katti SB (2004) CP-MLR\/PLS directed structure-activity modeling of the HIV-1RT inhibitory activity of 2, 3-diaryl-1, 3-thiazolidin-4-ones. QSAR Comb Sci 23:234\u2013244","journal-title":"QSAR Comb Sci"},{"key":"9667_CR20","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1016\/j.bmc.2005.07.063","volume":"13","author":"RK Rawal","year":"2005","unstructured":"Rawal RK, Prabhakar YS, Katti SB, Clercq ED (2005) 2-(Aryl)-3- furan-2-ylmethylthiazolidin-4-ones as selective HIV-RT inhibitors. Bioorg Med Chem 13:6771\u20136776","journal-title":"Bioorg Med Chem"},{"key":"9667_CR21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/qsar.200630040","volume":"26","author":"RK Rawal","year":"2007","unstructured":"Rawal RK, Prabhakar YS, Katti SB (2007) Molecular surface features in modeling the HIV-1 RT inhibitory activity of 2-(2, 6-disubstituted phenyl)-3-(substituted pyrimidin-2-yl)-thiazolidin-4-ones. QSAR Comb Sci 26:398\u2013406","journal-title":"QSAR Comb Sci"},{"key":"9667_CR22","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ejmech.2007.12.015","volume":"43","author":"RK Rawal","year":"2008","unstructured":"Rawal RK, Tripathi R, Katti SB, Pannecouque C, Clercq ED (2008) Design and synthesis of 2-(2, 6-dibromo-phenyl)-3-heteroaryl-1, 3- thiazolidin-4-ones as anti-HIV agents. Eur J Med Chem 43:2800\u20132806","journal-title":"Eur J Med Chem"},{"key":"9667_CR23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jmgm.2008.11.006","volume":"27","author":"V Murugesan","year":"2009","unstructured":"Murugesan V, Prabhakar YS, Katti SB (2009) CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. J Mol Graph Model 27:735\u2013743","journal-title":"J Mol Graph Model"},{"key":"9667_CR24","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1016\/j.bmc.2011.09.018","volume":"19","author":"V Murugesan","year":"2011","unstructured":"Murugesan V, Tiwari VS, Saxena R, Tripathi R, Paranjape R, Kulkarni S, Makwana N, Suryawanshi R, Katti SB (2011) Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 19:6919\u20136926","journal-title":"Bioorg Med Chem"},{"key":"9667_CR25","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.2174\/092986712803833326","volume":"19","author":"RK Rawal","year":"2012","unstructured":"Rawal RK, Murugesan V, Katti SB (2012) Structure-activity relationship studies on clinically relevant HIV-1 NNRTIs. Curr Med Chem 19:5364\u20135380","journal-title":"Curr Med Chem"},{"key":"9667_CR26","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer III","year":"1988","unstructured":"Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959\u20135967","journal-title":"J Am Chem Soc"},{"key":"9667_CR27","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (COMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146","journal-title":"J Med Chem"},{"key":"9667_CR28","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1021\/jm0500323","volume":"48","author":"DM Himmel","year":"2005","unstructured":"Himmel DM, Das K, Clark AD Jr, Hughes SH, Benjahad A, Oumouch S, Guillemont J, Coupa S, Poncelet A, Csoka I, Meyer C, Andries K, Nguyen CH, Grierson DS, Arnold E (2005) Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. J Med Chem 48:7582\u20137591","journal-title":"J Med Chem"},{"key":"9667_CR29","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","volume":"53","author":"EB Lansdon","year":"2010","unstructured":"Lansdon EB, Brendza KM, Hung M, Wang R, Mukund S, Jin D, Birkus G, Kutty N, Liu X (2010) Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design. J Med Chem 53:4295\u20134299","journal-title":"J Med Chem"},{"key":"9667_CR30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1006\/jmbi.2001.4988","volume":"312","author":"J Ren","year":"2001","unstructured":"Ren J, Nichols C, Bird L, Chamberlain P, Weaver K, Short S, Stuart DI, Stammers DK (2001) Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Mol Biol 312:795\u2013805","journal-title":"J Mol Biol"},{"key":"9667_CR31","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1021\/jm301294g","volume":"55","author":"P Chong","year":"2012","unstructured":"Chong P, Sebahar P, Youngman M, Garrido D, Zhang H, Stewart EL, Nolte RT, Wang L, Ferris RG, Edelstein M, Weaver K, Mathis A, Peat A (2012) Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. J Med Chem 55:10601","journal-title":"J Med Chem"},{"key":"9667_CR32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132789","journal-title":"J Comput Chem"},{"key":"9667_CR33","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","volume":"10","author":"M Clark","year":"1989","unstructured":"Clark M, Cramer RD III, Van Opdenbosch N (1989) Opdenbosch. Validation of the general-purpose tripos 5.2 force field. J Comput Chem 10:982\u20131012","journal-title":"J Comput Chem"},{"key":"9667_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00125017","volume":"4","author":"MT Barakat","year":"1990","unstructured":"Barakat MT, Dean PM (1990) Molecular structure matching by simulated annealing. I. A comparison between different cooling schedules. J Comput Aided Mol Des 4:295\u2013316","journal-title":"J Comput Aided Mol Des"},{"key":"9667_CR35","unstructured":"SYBYL, version 7.3 (2006) Tripos Associates, St. Louis, MO"},{"key":"9667_CR36","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (COMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146","journal-title":"J Med Chem"},{"key":"9667_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci00063a006","volume":"29","author":"VN Viswanadhan","year":"1989","unstructured":"Viswanadhan VN, Ghose AK, Revenkar GR, Robins RK (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structureactivity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring antibiotics. J Chem Inf Comput Sci 29:163\u2013172","journal-title":"J Chem Inf Comput Sci"},{"key":"9667_CR38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/jmbi.1994.1223","volume":"237","author":"G Klebe","year":"1994","unstructured":"Klebe G (1994) The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. J Mol Biol 237:212\u2013235","journal-title":"J Mol Biol"},{"key":"9667_CR39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0079-6468(08)70281-9","volume":"25","author":"L Stahle","year":"1988","unstructured":"Stahle L, Wold S (1988) 6 multivariate data analysis and experimental design in biomedical research. Prog Med Chem 25:291\u2013338","journal-title":"Prog Med Chem"},{"key":"9667_CR40","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","volume":"22","author":"JD Thompson","year":"1994","unstructured":"Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673\u20134680","journal-title":"Nucleic Acids Res"},{"key":"9667_CR41","first-page":"95","volume":"41","author":"TA Hall","year":"1999","unstructured":"Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symp Ser 41:95\u201398","journal-title":"Nucleic Acids Symp Ser"},{"key":"9667_CR42","unstructured":"MOE: The Molecular Operating Environment from Chemical Computing Group Inc., 1255 University St., Suite 1600, Montreal, Quebec, Canada H3B 3X3. http:\/\/www.chemcomp.com"},{"key":"9667_CR43","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812\u20133814","journal-title":"Nucleic Acids Res"},{"key":"9667_CR44","doi-asserted-by":"crossref","unstructured":"Mi H, Guo N, Kejariwal A, Thomas PD (2007) PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res 35(Database issue):D247\u2013D252","DOI":"10.1093\/nar\/gkl869"},{"key":"9667_CR45","unstructured":"Capriotti E, Fariselli P, Casadio R (2005) I-mutant 2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33(Web Server issue):306\u2013310"},{"key":"9667_CR46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/nar\/gkl190","volume":"34","author":"V Parthiban","year":"2006","unstructured":"Parthiban V, Gromiha MM, Schomburg D (2006) CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Res 34:239\u2013242","journal-title":"Nucleic Acids Res"},{"key":"9667_CR47","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1093\/nar\/gkg565","volume":"31","author":"L Willard","year":"2003","unstructured":"Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, Wishart DS (2003) VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 31:3316\u20133319","journal-title":"Nucleic Acids Res"},{"key":"9667_CR48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105\u2013132","journal-title":"J Mol Biol"},{"key":"9667_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.compbiomed.2004.09.006","volume":"36","author":"A Sillero","year":"2006","unstructured":"Sillero A, Maldonado A (2006) Isoelectric point determination of proteins and othermacromolecules: oscillating method. Comput Biol Med 36:157\u2013166","journal-title":"Comput Biol Med"},{"key":"9667_CR50","unstructured":"Calculation of protein isoelectric point. http:\/\/isoelectric.ovh.org\/"},{"key":"9667_CR51","doi-asserted-by":"crossref","first-page":"e18577","DOI":"10.1371\/journal.pone.0018577","volume":"6","author":"BM Krenn","year":"2011","unstructured":"Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Nakowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, Cinatl J, Michaelis M, Wressnigg N, Sturlan S, Ferko B, Batishchev OV, Indenbom AV, Zhu R, Kastner M, Hinterdorfer P, Kiselev O, Muster T, Romanova J (2011) Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS ONE 6:e18577","journal-title":"PLoS ONE"},{"key":"9667_CR52","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0969-2126(00)00513-X","volume":"8","author":"J Ren","year":"2000","unstructured":"Ren J, Milton J, Weaver KL, Short SA, Stuart DI, Stammers DK (2000) Structural basis for the resilience of Efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase. Structure\u00a08:1089\u20131094","journal-title":"Structure"},{"key":"9667_CR53","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1073\/pnas.0711209105","volume":"105","author":"K Das","year":"2008","unstructured":"Das K, Bauman JD, Clark AD Jr, Frenkel YV, Lewi PJ, Shatkin AJ, Hughes SH, Arnold E (2008) High-resolution structures of HIV-1 reverse transcriptase\/TMC278 complexes: strategic flexibility explains potency against resistance mutations. PNAS 105:1466\u20131471","journal-title":"PNAS"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-013-9667-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9667-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T05:32:15Z","timestamp":1563514335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-013-9667-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["9667"],"URL":"https:\/\/doi.org\/10.1007\/s10822-013-9667-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}